IP Verse

Marshall patent opposition analysis

The comprehensive analysis of Marshall opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Marshall

Stay updated with the latest patent oppositions filed by Marshall

Patent NumberTitleApplicantOpposition DateOpposition Company
EP2877201
A Liquid Formulation Of Long-Acting Insulin And Insulinotropic PeptideHANMI PHARMMar 5, 2020JAMES POOLE
EP2213284
Preparation For Application To Body Surface And Preparation Holding Sheet For Application To Body SurfaceBIOSERENTACHAug 15, 2018LEO PHARMA
EP2699593
Beta-2 Microglobulin-Deficient CellsUNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATIONMay 30, 2018JAMES POOLE
EP2334199
Process For Reducing The Fluoride Content When Producing Proteinaceous Concentrates From KrillRIMFROSTMar 28, 2018JAMES POOLE
EP2697397
Safe Sequencing SystemTHE JOHNS HOPKINS UNIVERSITYJan 5, 2018JAMES POOLE
EP2266958
Antiviral AgentSHIONOGINov 28, 2017MERCK & CO., INC.
EP2318552
Methods For Stratifying And Annotating Cancer Drug Treatment OptionsAUEONAug 23, 2017JAMES POOLE
EP1644412
Modified Antibody Fab FragmentsCELLTECH R & DJun 9, 2016JAMES POOLE
EP2233474
Condensed Aminodihydrothiazine DerivativeEISAI R&D MANAGEMENTMay 5, 2016ELI LILLY
EP2445855
Carbohydrate Route To Para-Xylene And Terephthalic AcidUOPJan 22, 2016MICROMIDAS

Top clients of Marshall

Top companies who are the clients of Marshall

CompanyTotal
JAMES POOLE7
ELI LILLY1
CELLULAR RESEARCH1
MERCK & CO., INC.1
MICROMIDAS1
NOVARTIS1
LEO PHARMA1